Triggering receptor expressed on myeloid cells-2 (TREM2) is expressed on TAMs and promotes immunosuppressive microenvironment formation and tumorigenesis in lung cancer, highlighting its potential as an immunotherapy target [88]. Here, TREM2 is linked to lung cancer.